首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones
【24h】

Synthesis, stereochemical identification, and selective inhibitory activity against human monoamine oxidase-B of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones

机译:2-甲基环己叉基-(4-芳基噻唑-2-基)hydr的合成,立体化学鉴定和对人单胺氧化酶-B的选择性抑制活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A series of 2-methylcyclohexylidene-(4-arylthiazol-2-yl)hydrazones have been investigated for their ability to inhibit selectively the activity of the human A and B isoforms of monoamine oxidase (MAO). The target compounds, which present a stereogenic center on the cyclohexane ring, were obtained as pure (R) and (S) enantiomers by enantioselective HPLC. The absolute configuration of homochiral forms isolated on a semipreparative scale was obtained by a combined strategy based on chemical correlation and single-crystal X-ray diffraction. All compounds showed higher activity against the human MAO-B isoform with IC50 values ranging between 26.81 +/- 2.74 mu M and 14.20 +/- 0.26 nM, and the assays carried out on the pure enantiomers showed higher activity for the (R) form. A computational study was performed by molecular mechanics, DFT-based quantomechanics, and docking techniques on the most active and human MAO-B selective inhibitor 8.
机译:已经研究了一系列2-甲基环己叉基-(4-芳基噻唑-2-基)hydr酮具有选择性抑制单胺氧化酶(MAO)的人A和B同工型活性的能力。通过对映选择性HPLC获得纯的(R)和(S)对映异构体,在环己烷环上具有立体异构中心的目标化合物。通过基于化学相关性和单晶X射线衍射的组合策略,获得了半制备规模上分离的同手性形式的绝对构型。所有化合物均显示出对人MAO-B同工型的更高活性,IC50值介于26.81 +/- 2.74μM和14.20 +/- 0.26 nM之间,对纯对映异构体进行的测定表明对(R)形式具有更高的活性。通过分子力学,基于DFT的量子力学和对接技术对最活跃的人MAO-B选择性抑制剂8进行了计算研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号